BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Celldex Therapeutics, Inc. (CLDX) Reports Second Quarter 2014 Results 8/6/2014 4:29:53 PM
Celldex Therapeutics, Inc. (CLDX) Announces Senior Leadership Promotions 7/30/2014 10:43:37 AM
Celldex Therapeutics, Inc. (CLDX) To Report Second Quarter 2014 Financial Results And Host Corporate 2014 Objectives Update Call 7/18/2014 6:35:18 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Collaboration For Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 5/29/2014 9:52:32 AM
Celldex Therapeutics, Inc. (CLDX) Announces Varlilumab (CDX-1127) Phase 1 Clinical Data To Be Presented At American Society of Clinical Oncology Annual Meeting 2014 5/14/2014 3:06:58 PM
Bristol-Myers Squibb Company (BMY) And Celldex Therapeutics, Inc. (CLDX) Announce Clinical Trial Collaboration To Evaluate The Combination Of Investigational Immunotherapies Nivolumab And Varlilumab 5/14/2014 8:34:17 AM
Celldex Therapeutics, Inc. (CLDX) To Present Antibody-Drug Conjugate CDX-014 Preclinical Proof Of Concept Data At American Association for Cancer Research 2014 4/3/2014 12:08:25 PM
Celldex Therapeutics, Inc. (CLDX) Reports Third Quarter 2013 Financial Results 11/8/2013 9:18:42 AM
Celldex Therapeutics, Inc. (CLDX)' CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity in Phase 1 Dose-Escalation Study 11/7/2013 9:24:38 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation at the Leerink Swann and Company Rare Disease Roundtable 9/26/2013 9:28:57 AM
12345678910...